Effect of chronic administration of morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the concentration of cGMP in brain regions and spinal cord of the mouse

Peptides

Volumn 18, Issue 10, 1997, Pages 1629-1634

  Bhargava, Hemendra N ^a   Cao, Ying Jun ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Brain regions; Cyclic GMP levels; Multiple opioid receptors; Opioid tolerance and abstinence; Spinal cord

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; CYCLIC GMP; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE SULFATE; MU OPIATE RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG TOLERANCE; DRUG WITHDRAWAL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; BRAIN; CYCLIC GMP; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; MALE; MICE; MORPHINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTORS, OPIOID; SPINAL CORD; UP-REGULATION;

EID: 0031418037     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00233-7     Document Type: Article

References (51)

1. G-nitro-L-arginine methyl ester. Life Sci. 52:1993;L 245-PL 249.
2. Barjavel M. J., Bhargava H. N. Effect of morphine tolerance and abstinence on nitric oxide synthase activity in brain regions and spinal cord of the mouse. Soc. Neurosci. Abstr. 20:1994;A1234.
3. Barjavel M. J., Bhargava H. N. Effect of opioid receptor agonists on nitric oxide synthase activity in rat cerebral cortex homogenate. Neurosci. Lett. 181:1994;27-30.
4. Bhargava H. N. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self-administrative behavior. Pharmacol. Rev. 46:1994;293-324.
5. Bhargava H. N. Nitric oxide synthase inhibition blocks tolerance to the analgesic action of U-50,488H, a κ-opioid receptor agonist in the rat. Pharmacology. 48:1994;234-241.
6. Bhargava H. N. Noncompetitive antagonism of NMDA receptor inhibits tolerance to U-50,488H, a κ-opiate receptor agonist in the rat. Gen. Pharmacol. 26:1995;1055-1060.
7. Bhargava H. N. Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. Gen. Pharmacol. 26:1995;1049-1053.
8. Bhargava H. N. Enhancement of morphine actions in morphine-naive and morphine-tolerant mice by LY235959, a noncompetitive antagonist of the NMDA receptor. Gen. Pharmacol. 28:1997;61-64.
9. 5] enkephalin in the mouse. Peptides. 18:1997;797-800.
10. 3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a κ-opioid receptor agonist. Brain Res. 749:1997;347-350.
11. Bhargava, H. N.; Kumar, S. Effect of multiple injections of κ-opioid receptor agonist on the nitric oxide synthase activity in the brain regions and spinal cord of mice. Gen. Pharmacol. 1997 (in press).
12. Bhargava H. N., Matwyshyn G. A. Dizocilpine (MK-801) blocks tolerance to its analgesic but not to the hyperthermic effect of morphine in the rat. Pharmacology. 47:1993;344-350.
13. Bhargava H. N., Reddy P. L., Gudehithlu K. P. Down-regulation of N-methly-D-aspartate (NMDA) receptors of brain regions and spinal cord of rats treated chronically with morphine. Gen. Pharmacol. 26:1995;131-136.
14. Bhargava H. N., Thorat S. N. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a κ-opioid receptor agonist, in the mouse. Brain Res. 649:1994;111-116.
15. Bhargava H. N., Thorat S. N. Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome. Pharmacology. 52:1996;86-91.
16. 2-opioid receptor agonist in mice. Brain Res. 719:1996;56-61.
17. 5 enkephalin and morphine in the mouse. Neuropeptides. 30:1996;219-223.
18. 2-opioid receptor agonists in mice. Br. J. Pharmacol. 119:1996;1586-1590.
19. Bredt D. S., Hwang P. M., Snyder S. H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:1990;768-770.
20. Bredt D. S., Snyder S. H. Nitric oxide, a novel neuronal messenger. Neuron. 8:1992;3-11.
21. Cao Y. J., Bhargava H. N. Effects of ibogaine on the development of tolerance to the antinociceptive action of μ-, δ- and κ-opioid receptor agonists in mice. Brain Res. 752:1997;250-254.
22. Cappendijik S. L. T., deVries R., Dzoljic M. R. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci. Lett. 192:1993;97-100.
23. Cappendijik S. L. T., Duval S. Y., deVries R., Dzoljic M. R. Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats. Neurosci. Lett. 183:1995;67-70.
24. 3H]MK-801 to brain regions and spinal cord of mice treated chronically with morphine. Gen. Pharmacol. 27:1996;91-94.
25. 3H]MK-801 to brain regions and spinal cord of the rat. Brain Res. 639:1994;269-274.
26. Johnson S. M., Fleming W. W. Mechanisms of cellular adaptive sensitivity changes application to tolerance and dependence . Pharmacol. Rev. 41:1989;435-488.
27. Kimes A. S., Vaupel D. B., London E. D. Attenuation of some signs of opioid withdrawal by inhibition of nitric oxide synthase. Psychopharmacology. 112:1993;521-524.
28. Knowles R., Palacios M., Palmer R. M. J., Moncada S. Formation of nitric oxide from L-arginine in the central nervous system A transduction mechanism for stimulation of the soluble guanylyl cyclase . Proc. Natl. Acad. Sci. USA. 86:1989;5159-5162.
29. Kolesnikov Y. A., Ferkany J., Pasternak G. W. Blockade of mu and kappa opioid analgesic tolerance by NPC 17742, a novel NMDA receptor antagonist. Life Sci. 53:1993;1489-1494.
30. Kolesnikov Y. A., Pick C. G., Ciszewska G., Pasternak G. W. Blockade of tolerance to morphine but not to κ-opioids by nitric oxide synthase inhibitors. Proc. Natl. Acad. Sci. USA. 90:1993;5162-5166.
31. 2-opioid receptor agonists in mice. The Pharmacologist. 39:1997;105.
32. Kumar S., Bhargava H. N. Time course of the changes in central nitric oxide synthase activity following chronic treatment with morphine in the mouse reversal by naltrexone . Gen. Pharmacol. 29:1997;223-227.
33. Lau W. S., Kumar S., Bhargava H. N. Nitric oxide synthase (NOS) activity in the cerebellum and cortex of morphine tolerant mice kinetic studies . The Pharmacologist. 39:1997;106.
34. Leza J. C., Lizasoain I., San-Martin-Clark O., Lorenzo P. Morphine-induced changes in cerebral and cerebellar nitric oxide synthase activity. Eur. J. Pharmacol. 285:1995;95-98.
35. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
36. Lust D. W., Feussner G. K., Passonneau J. V., McCandless D. W. Distribution of cyclic nucleotides in layers of the cerebellum after decapitation. J. Cyclic Nucleotide Res. 7:1981;333-337.
37. Lutfy K., Hurlbut D. E., Weber E. Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 616:1993;83-88.
38. Marek P., Ben-Eliyahu S., Gold M., Liebeskind J. C. Excitatory aminoacid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547:1991;77-81.
39. Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide Physiology, pathophysiology and pharmacology . Pharmacol. Rev. 43:1991;109-142.
40. Moore P. K., Babbedge R. C., Wallace P., Gaffen Z. A., Hart S. L. 7-Nitroindazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108:1993;296-297.
41. Okada D. Two pathways of cyclic GMP production through glutamate receptor-mediated nitric oxide synthesis. J. Neurochem. 59:1992;1203-1210.
42. Rasmussen K., Fuller R. W., Stockton M. E., Perry K. W., Swinford R. M., Ornstein P. L. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. Eur. J. Pharmacol. 197:1991;9-16.
43. Rubin E. H., Ferrendelli J. A. Distribution and regulation of cyclic nucleotide levels in cerebellum, in vivo. J. Neurochem. 29:1977;43-51.
44. Schmidt H. H. H. W., Wilke P., Evers B., Bohme E. Enzymatic formation of nitric oxide from L-arginine in bovine brain cytosol. Biochem. Biophys. Res. Commun. 165:1989;284-291.
45. G-monomethyl-L0arginine and MK-801 on the abstinence syndrome in morphine-dependent mice. Brain Res. 642:1994;153-159.
46. Thorat S. N., Reddy P. L., Bhargava H. N. Evidence for the role of nitric oxide in kappa opiate tolerance in mice. Brain Res. 621:1993;171-174.
47. Tiseo P. J., Inturrisi C. E. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY 274614. J. Pharmacol. Exp. Ther. 264:1993;1090-1096.
48. Trujillo K. A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
49. Vaupel D. B., Kimes A. S., London E. D. Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal. Psychopharmacology. 118:1995;361-368.
50. 1-receptor agonist. Peptides. 17:1996;233-236.
51. 2-opioid receptor agonist in mice. Peptide. 17:1996;619-623.